> 0 1 0 1 O
18 2 4 2 4 B-lower_bound
years 5 10 5 10 I-lower_bound
of 11 13 11 13 O
age 14 17 14 17 B-age

Able 0 4 18 22 O
and 5 8 23 26 O
willing 9 16 27 34 O
to 17 19 35 37 O
participate 20 31 38 49 O
in 32 34 50 52 O
the 35 38 53 56 O
full 39 43 57 61 O
12 44 46 62 64 B-upper_bound
months 47 53 65 71 I-upper_bound
of 54 56 72 74 O
the 57 60 75 78 O
study 61 66 79 84 O

Able 0 4 85 89 O
to 5 7 90 92 O
swallow 8 15 93 100 O
and 16 19 101 104 O
retain 20 26 105 111 O
oral 27 31 112 116 B-treatment
medication 32 42 117 127 I-treatment

Biopsy 0 6 128 134 B-treatment
confirmed 7 16 135 144 O
adenocarcinoma 17 31 145 159 B-cancer
of 32 34 160 162 I-cancer
the 35 38 163 166 I-cancer
prostate 39 47 167 175 I-cancer

Chemotherapy 0 12 176 188 B-treatment

Current 0 7 189 196 O
or 8 10 197 199 O
previous 11 19 200 208 O
use 20 23 209 212 O
of 24 26 213 215 O
5Î± 27 29 216 218 B-treatment
- 29 30 218 219 I-treatment
reductase 30 39 219 228 I-treatment
inhibitors 40 50 229 239 I-treatment
, 50 51 239 240 O
antiandrogen 52 64 241 253 B-treatment
drugs 65 70 254 259 I-treatment
, 70 71 259 260 O
metformin 72 81 261 270 B-treatment
, 81 82 270 271 O
oral 83 87 272 276 B-treatment
or 88 90 277 279 I-treatment
injectable 91 101 280 290 I-treatment
diabetes 102 110 291 299 I-treatment
drug 111 115 300 304 I-treatment

Diagnosis 0 9 305 314 O
of 10 12 315 317 O
Type 13 17 318 322 B-chronic_disease
1 18 19 323 324 I-chronic_disease
Diabetes 20 28 325 333 I-chronic_disease
Mellitus 29 37 334 342 I-chronic_disease

Gonadotropin 0 12 343 355 B-treatment
- 12 13 355 356 I-treatment
releasing 13 22 356 365 I-treatment
hormone 23 30 366 373 I-treatment
analogue 31 39 374 382 I-treatment
therapy 40 47 383 390 I-treatment

Hemoglobin 0 10 391 401 B-clinical_variable
A1C 11 14 402 405 I-clinical_variable
< 15 16 406 407 O
7.0 16 19 407 410 B-upper_bound
% 19 20 410 411 I-upper_bound

Known 0 5 412 417 O
hypersensitivity 6 22 418 434 O
to 23 25 435 437 O
metformin 26 35 438 447 B-allergy_name

Male 0 4 448 452 B-gender

Metastatic 0 10 453 463 B-cancer
Prostate 11 19 464 472 I-cancer
Cancer 20 26 473 479 I-cancer

Prostate 0 8 480 488 B-clinical_variable
Specific 9 17 489 497 I-clinical_variable
Antigen 18 25 498 505 I-clinical_variable
Doubling 26 34 506 514 I-clinical_variable
Time 35 39 515 519 I-clinical_variable
< 40 41 520 521 O
6 42 43 522 523 B-upper_bound
months 44 50 524 530 I-upper_bound

abnormal 0 8 531 539 O
liver 9 14 540 545 O
function 15 23 546 554 O
test 24 28 555 559 O
( 29 30 560 561 O
total 30 35 561 566 B-clinical_variable
bilirubin 36 45 567 576 I-clinical_variable
, 45 46 576 577 O
aspartate 47 56 578 587 B-clinical_variable
aminotransferase 57 73 588 604 I-clinical_variable
, 73 74 604 605 O
alanine 75 82 606 613 B-clinical_variable
aminotransferase 83 99 614 630 I-clinical_variable
, 99 100 630 631 O
alkaline 101 109 632 640 B-clinical_variable
phosphatase 110 121 641 652 I-clinical_variable
or 122 124 653 655 O
serum 125 130 656 661 B-clinical_variable
creatinine 131 141 662 672 I-clinical_variable
above 142 147 673 678 O
upper 148 153 679 684 O
limit 154 159 685 690 O
of 160 162 691 693 O
normal 163 169 694 700 O
) 169 170 700 701 O

adequately 0 10 702 712 O
treated 11 18 713 720 O
non 19 22 721 724 B-cancer
- 22 23 724 725 I-cancer
melanoma 23 31 725 733 I-cancer
skin 32 36 734 738 I-cancer
cancer 37 43 739 745 I-cancer

any 0 3 746 749 O
condition 4 13 750 759 O
associated 14 24 760 770 O
with 25 29 771 775 O
increased 30 39 776 785 O
risk 40 44 786 790 O
of 45 47 791 793 O
metformin 48 57 794 803 B-treatment
associated 58 68 804 814 O
lactic 69 75 815 821 O
acidosis 76 84 822 830 O

any 0 3 831 834 O
unstable 4 12 835 843 O
, 12 13 843 844 O
serious 14 21 845 852 O
co 22 24 853 855 O
- 24 25 855 856 O
existing 25 33 856 864 O
medical 34 41 865 872 B-chronic_disease
conditions 42 52 873 883 I-chronic_disease
including 53 62 884 893 O
but 63 66 894 897 O
not 67 70 898 901 O
limited 71 78 902 909 O
to 79 81 910 912 O
myocardial 82 92 913 923 B-chronic_disease
infarction 93 103 924 934 I-chronic_disease
, 103 104 934 935 O
coronary 105 113 936 944 B-treatment
bypass 114 120 945 951 I-treatment
surgery 121 128 952 959 I-treatment
, 128 129 959 960 O
unstable 130 138 961 969 B-chronic_disease
angina 139 145 970 976 I-chronic_disease
, 145 146 976 977 O
cardiac 147 154 978 985 B-chronic_disease
arrhythmias 155 166 986 997 I-chronic_disease
, 166 167 997 998 O
clinically 168 178 999 1009 O
evident 179 186 1010 1017 O
congestive 187 197 1018 1028 B-chronic_disease
heart 198 203 1029 1034 I-chronic_disease
failure 204 211 1035 1042 I-chronic_disease
, 211 212 1042 1043 O
or 213 215 1044 1046 O
cerebrovascular 216 231 1047 1062 B-chronic_disease
accident 232 240 1063 1071 I-chronic_disease
within 241 247 1072 1078 O
6 248 249 1079 1080 B-upper_bound
months 250 256 1081 1087 I-upper_bound
prior 257 262 1088 1093 I-upper_bound
to 263 265 1094 1096 O
screening 266 275 1097 1106 O

history 0 7 1107 1114 O
of 8 10 1115 1117 O
any 11 14 1118 1121 O
illness 15 22 1122 1129 O
( 23 24 1130 1131 O
including 24 33 1131 1140 O
psychiatric 34 45 1141 1152 B-chronic_disease
) 45 46 1152 1153 O
that 47 51 1154 1158 O
, 51 52 1158 1159 O
in 53 55 1160 1162 O
the 56 59 1163 1166 O
opinion 60 67 1167 1174 O
of 68 70 1175 1177 O
the 71 74 1178 1181 O
investigator 75 87 1182 1194 O
, 87 88 1194 1195 O
might 89 94 1196 1201 O
confound 95 103 1202 1210 O
the 104 107 1211 1214 O
results 108 115 1215 1222 O
of 116 118 1223 1225 O
the 119 122 1226 1229 O
study 123 128 1230 1235 O
or 129 131 1236 1238 O
post 132 136 1239 1243 O
an 137 139 1244 1246 O
additional 140 150 1247 1257 O
risk 151 155 1258 1262 O
to 156 158 1263 1265 O
the 159 162 1266 1269 O
subject 163 170 1270 1277 O

history 0 7 1278 1285 O
of 8 10 1286 1288 O
megaloblastic 11 24 1289 1302 B-chronic_disease
anemia 25 31 1303 1309 I-chronic_disease

history 0 7 1310 1317 O
of 8 10 1318 1320 O
other 11 16 1321 1326 O
malignancies 17 29 1327 1339 B-cancer

history 0 7 1340 1347 O
or 8 10 1348 1350 O
current 11 18 1351 1358 O
evidence 19 27 1359 1367 O
of 28 30 1368 1370 O
substance 31 40 1371 1380 O
abuse 41 46 1381 1386 O
within 47 53 1387 1393 O
12 54 56 1394 1396 B-upper_bound
months 57 63 1397 1403 I-upper_bound
of 64 66 1404 1406 O
screening 67 76 1407 1416 O

hormonal 0 8 1417 1425 B-treatment
therapy 9 16 1426 1433 I-treatment

non 0 3 1434 1437 B-cancer
- 3 4 1437 1438 I-cancer
muscle 4 10 1438 1444 I-cancer
invasive 11 19 1445 1453 I-cancer
bladder 20 27 1454 1461 I-cancer
cancer 28 34 1462 1468 I-cancer

oral 0 4 1469 1473 B-treatment
glucocorticoid 5 19 1474 1488 I-treatment
therapy 20 27 1489 1496 I-treatment

other 0 5 1497 1502 O
solid 6 11 1503 1508 B-cancer
tumors 12 18 1509 1515 I-cancer
curatively 19 29 1516 1526 O
treated 30 37 1527 1534 O
with 38 42 1535 1539 O
no 43 45 1540 1542 O
evidence 46 54 1543 1551 O
of 55 57 1552 1554 O
disease 58 65 1555 1562 O
for 66 69 1563 1566 O
at 70 72 1567 1569 O
least 73 78 1570 1575 O
5 79 80 1576 1577 B-lower_bound
years 81 86 1578 1583 I-lower_bound

participation 0 13 1584 1597 O
in 14 16 1598 1600 O
any 17 20 1601 1604 O
investigational 21 36 1605 1620 B-treatment
or 37 39 1621 1623 I-treatment
marketed 40 48 1624 1632 I-treatment
drug 49 53 1633 1637 I-treatment
trial 54 59 1638 1643 I-treatment
within 60 66 1644 1650 O
30 67 69 1651 1653 B-upper_bound
days 70 74 1654 1658 I-upper_bound
prior 75 80 1659 1664 I-upper_bound
to 81 83 1665 1667 O
screening 84 93 1668 1677 O
or 94 96 1678 1680 O
during 97 103 1681 1687 O
study 104 109 1688 1693 O
period 110 116 1694 1700 O

stage 0 5 1701 1706 B-cancer
1 6 7 1707 1708 I-cancer
melanoma 8 16 1709 1717 I-cancer

